Cargando…
Sulfotransferase 1C2 promotes hepatocellular carcinoma progression by enhancing glycolysis and fatty acid metabolism
BACKGROUND: Hepatocellular carcinoma (HCC) is aggressive liver cancer. Despite advanced imaging and other diagnostic measures, HCC in a significant portion of patients had reached the advanced stage at the first diagnosis. Unfortunately, there is no cure for advanced HCC. As a result, HCC is still a...
Autores principales: | Jiang, Liya, Xu, Fang, Li, Chenglong, Liu, Ting, Zhao, Qianwei, Liu, Yixian, Zhao, Ying, Li, Yamei, Zhang, Zhendong, Tang, Xiaolei, Zhang, Jintao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225225/ https://www.ncbi.nlm.nih.gov/pubmed/36880364 http://dx.doi.org/10.1002/cam4.5759 |
Ejemplares similares
-
Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
por: Zhao, Qianwei, et al.
Publicado: (2020) -
Dysregulation of phosphoproteins in hepatocellular carcinoma revealed via quantitative analysis of the phosphoproteome
por: Liu, Yixian, et al.
Publicado: (2021) -
Estrogen Sulfotransferase: Intracrinology Meets Metabolic Diseases
por: Mauvais-Jarvis, Franck
Publicado: (2012) -
The Environmental Pollutant Bromophenols Interfere With Sulfotransferase That Mediates Endocrine Hormones
por: Dai, Zhihong, et al.
Publicado: (2022) -
A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma
por: Feng, Yilu, et al.
Publicado: (2020)